在格鲁吉亚州通过HCV消除计划治愈的患者中评估酒精使用行为
Maia Butsashvili1,2, Lasha Gulbiani3,4, Giorgi Kanchelashvili1,2
1Health Research Union, 8 Nutsubidze str. Tbilisi, Tbilisi, 0171, Georgia.
BMC research notes
|June 10, 2024
概括
肝炎C病毒 (HCV) 患者在治疗后经常恢复饮酒. 在HCV治愈后戒酒可显著改善肝纤维化,强调持续清醒对肝脏健康的重要性.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒性肝炎研究研究
- 公共卫生 公共卫生
背景情况:
- 肝炎C病毒 (HCV) 感染对全球健康造成重大负担.
- 持续病毒反应 (SVR) 是HCV治疗的主要目标.
- 治疗后饮酒对HCV患者肝脏健康的影响需要进一步研究.
研究的目的:
- 调查自我报告的饮酒行为与肝脏健康结果之间的关联.
- 了解在HCV患者中达到SVR后饮酒习惯的作用.
- 评估HCV患者中酒精消费的流行程度和对其影响的信念.
主要方法:
- 在格鲁吉亚的HCV治疗诊所进行的横截面研究.
- 面对面采访,使用专门设计的问卷.
- 收集有关饮酒行为,对酒精影响的认识和肝纤维化状态的数据.
主要成果:
- 在治疗期间,高比例的HCV患者 (97.8%) 禁酒,但大多数 (76.6%) 在SVR后恢复饮酒.
- 肝纤维化改善在HCV诊断后和达到SVR后戒酒的患者中明显更常见.
- 对酒精对肝纤维化的有害影响的认识很高 (94.2%),但对适度饮酒的误解仍然存在.
结论:
- 在HCV治疗后戒酒与更好的肝纤维化结局有关.
- 患者对饮酒风险的教育,即使是适度饮酒,在SVR后至关重要.
- 未来的干预措施应侧重于支持持续的酒精戒断,以确保HCV幸存者的最佳肝脏健康.
相关概念视频
CNS Depressants: Alcohol and Nicotine
1.7K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.7K
Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Hepatitis
86
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42
Hepatic Encephalopathy
53
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53


